EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, Cytotoxic Effect Evaluation and Molecular Docking of (R)‐Camphor‐Based Thiazolidinone‐Isoxazole and Thiazolidinone‐1,2,3‐triazole Hybrids“

Abdellah N'ait Ousidi, Abdoullah Bimoussa, Mohammed Loubidi, Mourad Fawzi, Yassine Laamari, Ali Oubella, Mohamed Maatallah, Sabine Berteina‐Raboin, Aziz Auhmani, Mohamed Labd Taha, Hamid Morjani, Moulay Youssef Ait Itto

ChemistrySelect · 09.01.2023 · 8 (1)

DOI: 10.1002/slct.202203349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 02.01.2023. Verfasst von Abdellah N'ait Ousidi und 11 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A variety of hybrid compounds, combining a camphor thiazolidinone skeleton with either 1,2,3‐triazole or isoxazole nucleus, have been synthesized from natural (R)‐camphor. Our efficient procedure consists in a transformation of the (R)‐camphor into the corresponding thiazolidin‐4‐one. The latter is then N‐alkylated with propargyl bromide before submitting the resulting product to 1,3‐dipolar cycloaddition reactions, with a series of nitrile oxides and arylazides respectively. The chemical structures of all the newly synthesized hybrids were established using ( 1 H and 13 C) NMR and HRMS analysis. Preliminary in‐vitro cytotoxic assays on three human cancer cell lines MCF‐7 (breast), A‐549 (prostate) and HT‐1080 (fibrosarcoma) were performed on all the compounds. The thiazolidinone‐1,2,3‐isoxazole hybrid 8 c was revealed to be the most active with IC50 values ranging from 11.62±4.52 μM to 16.92±1.22 μM against selected cancer cells. Molecular docking studies carried out on the three compounds 8 c , 9 a and 9 c , confirmed, as expected, that these compounds possess a great inhibition potential against BCl‐2 protein, Caspase‐3 and COX‐2 enzymes. The results showed that the selected compounds had a significant binding property which could lead to the development of novel BCl‐2, Caspase‐3 and −2 inhibitors with improved selectivity. Finally, an ADME study was applied and proved the promising activity of the new compounds as a new oral anti‐inflammatory agent.

Zitieren

APA

Ousidi, A. N., Bimoussa, A., Loubidi, M., Fawzi, M., Laamari, Y., Oubella, A., Maatallah, M., Berteina‐Raboin, S., Auhmani, A., Taha, M. L., Morjani, H., & Itto, M. Y. A. (2023). Design, Synthesis, Cytotoxic Effect Evaluation and Molecular Docking of (R)‐Camphor‐Based Thiazolidinone‐Isoxazole and Thiazolidinone‐1,2,3‐triazole Hybrids“. ChemistrySelect, 8(1). https://doi.org/10.1002/slct.202203349

Vancouver

Ousidi AN, Bimoussa A, Loubidi M, Fawzi M, Laamari Y, Oubella A, et al. Design, Synthesis, Cytotoxic Effect Evaluation and Molecular Docking of (R)‐Camphor‐Based Thiazolidinone‐Isoxazole and Thiazolidinone‐1,2,3‐triazole Hybrids“. ChemistrySelect. 2023;8(1). doi:10.1002/slct.202203349

BibTeX
@article{Ousidi2023,
  author = {Ousidi, Abdellah N'ait and Bimoussa, Abdoullah and Loubidi, Mohammed and Fawzi, Mourad and Laamari, Yassine and Oubella, Ali and Maatallah, Mohamed and Berteina‐Raboin, Sabine and Auhmani, Aziz and Taha, Mohamed Labd and Morjani, Hamid and Itto, Moulay Youssef Ait},
  title = {Design, Synthesis, Cytotoxic Effect Evaluation and Molecular Docking of (R)‐Camphor‐Based Thiazolidinone‐Isoxazole and Thiazolidinone‐1,2,3‐triazole Hybrids“},
  journal = {ChemistrySelect},
  year = {2023},
  volume = {8},
  number = {1},
  doi = {10.1002/slct.202203349}
}
Kostenlos starten →